Title : Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers.

Pub. Date : 2017 Dec

PMID : 28806472






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 WHAT IS KNOWN AND OBJECTIVE: Evogliptin (DA-1229), a novel dipeptidyl peptidase (DPP)-4 inhibitor with high potency and selectivity, was approved in Korea for the treatment of type 2 diabetes. 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one dipeptidyl peptidase 4 Homo sapiens
2 WHAT IS KNOWN AND OBJECTIVE: Evogliptin (DA-1229), a novel dipeptidyl peptidase (DPP)-4 inhibitor with high potency and selectivity, was approved in Korea for the treatment of type 2 diabetes. 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one dipeptidyl peptidase 4 Homo sapiens